Cite
HARVARD Citation
Reni, M. et al. (n.d.). O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. Annals of oncology. p. . [Online].